June 20, 2016
Sunnyvale, CA – Deep learning will transform medicine, but not in the way that many advocates think. Biological complexity, rare mutations and confounding factors work against us, so that even if we sequence 100,000 genomes, it won’t be enough.
Brendan Frey is engineering the future of personalized medicine. A professor in the University of Toronto’s Faculty of Applied Science & Engineering, he and his research group combine world-leading expertise in machine learning with more than a decade of experience in genomic medicine to teach computers to “read” and begin to make sense of the more than two-billion base pairs that make up the human genome.
Frey is also CEO of Deep Genomics, a startup that is inventing a new generation of computational technologies that can tell us what will happen within a cell when DNA is altered by genetic variation, whether natural or therapeutic. Deep Genomics recently secured $5 million in seed funding.
On Thursday, June 23, Frey will be speaking at BizSkule, an event hosted by U of T Engineering that invites top thinkers to illuminate hot topics in engineering, technology, industry and business — from the sharing economy to sports analytics, entertainment to the future of transportation.
Members of the media are invited to speak with Frey before or after his talk.
BizSkule: Brendan Frey & Deep Genomics
Date: Thursday, June 23, 2016
Time: 5-8 pm; talk starts at 6 pm
Location: Juniper Networks
1194 N Mathilda Ave. Sunnyvale, Calif. [map]
U of T Engineering
416-978-4498 (desk), 647-228-4358 (cell)